Highlights
ASX 200 ended marginally lower as miners posted gains but healthcare and finance sectors fell
Lithium miners advanced strongly following developments in US policy
IDP Education saw notable declines following earnings downgrade earlier in the week
The Australia equity market edged down slightly after early gains, as strength in the mining sector, including key lithium producers, was counterbalanced by losses in the healthcare and financial segments. The S&P/ASX 200 closed slightly lower, while the broader All Ordinaries and ASX 300 indexes followed a similar trajectory.
Mining stocks gain as lithium segment outperforms
The materials sector supported the index, particularly through gains among lithium producers. Mineral Resources Ltd (ASX:MIN) led the charge after favorable developments in US policy frameworks. Pilbara Minerals Ltd (ASX:PLS), IGO Ltd (ASX:IGO), and Liontown Resources Ltd (ASX:LTR) also advanced strongly. Large diversified miners BHP Group Ltd (ASX:BHP), Fortescue Ltd (ASX:FMG), and Rio Tinto Ltd (ASX:RIO) registered modest gains, contributing positively to the benchmark index.
Healthcare stocks weigh on overall performance
Healthcare emerged as the weakest-performing sector of the day. CSL Ltd (ASX:CSL), Sigma Healthcare Ltd (ASX:SIG), and Pro Medicus Ltd (ASX:PME) recorded losses, pressuring the overall index. Despite recent advancements in medical technology and product development in the sector, performance remained subdued through the trading session.
Financial sector performance mixed across major banks
The performance of major banks was mixed. Commonwealth Bank of Australia (ASX:CBA) and Westpac Banking Corporation (ASX:WBC) ended marginally higher. In contrast, National Australia Bank Ltd (ASX:NAB) and Australia and New Zealand Banking Group Ltd (ASX:ANZ) edged slightly lower. The financial sector’s subdued result was one of the key contributors to the overall index's lackluster performance.
Education sector sees sharp downside
IDP Education Ltd (ASX:IEL) recorded the steepest drop among ASX 200 constituents. The company’s decline followed a recent downward revision to earnings guidance due to constraints in key international student markets including Australia and the United States.
Deal updates and company-specific developments
Mayne Pharma Group Ltd (ASX:MYX) continued with its proposed acquisition plan involving US-based Cosette Pharmaceuticals, despite the latter issuing a termination notice. Catapult Group International Ltd (ASX:CAT) announced the acquisition of MIT spinoff Perch, aimed at strengthening its position in sports technology.
Tyro Payments Ltd (ASX:TYR) experienced a sharp decline following the resignation of its CEO and managing director Jon Davey, who is moving to a new role with a private equity-backed business. EMVision Medical Devices Ltd (ASX:EMV) appointed Ramsay Health Care’s CEO Carmel Monaghan to its board.
IperionX Ltd (ASX:IPX) advanced following the award of a defense-related contract. Lynas Rare Earths Ltd (ASX:LYC) gained amid reports of rare earths supply issues in Europe linked to recent export controls from China. Clarity Pharmaceuticals Ltd (ASX:CU6) rose on releasing results from a key clinical trial highlighting safety and effectiveness in imaging neuroendocrine tumors.